Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -23924.83x is 313% below its 5-year average of -5793.58x, near the low end of its 5-year range (-23924.83x–-995.14x).
As of the fiscal period ended Sunday, October 31, 2021. 279.12% below its 12-month average of -6310.68x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2021-10-31): -23924.83x.
INTEREST COVERAGE RATIO
-23924.83x
INTEREST COVERAGE RATIO AVG TTM
-6310.68x
INTEREST COVERAGE RATIO AVG 3Y
-5637.62x
INTEREST COVERAGE RATIO AVG 5Y
-5793.58x
INTEREST COVERAGE RATIO AVG 10Y
-1136.14x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-279.12%
CURRENT VS 3Y AVG
-324.38%
CURRENT VS 5Y AVG
-312.95%
CURRENT VS 10Y AVG
-2005.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-384234.67%
vs the sector median at left
PharmaCyte Biotech, Inc.
Market Cap
$4.62M
Interest Coverage Ratio
-23924.83x
TTM Avg
-6310.68x
3Y Avg
-5637.62x
5Y Avg
-5793.58x
Market Cap
$4.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.78M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.43M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$4.25M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$5.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | $4.62M | -23924.83x | -6310.68x | -5637.62x | -5793.58x |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.69M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.65M | -16.26x | N/A | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.78M | N/A | 1.10x | 1.10x | 1.10x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -765.53x | 1.76x | 1.76x | 1.76x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.25M | -21.32x | 128.62x | 128.62x | 128.62x |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.01M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.04M | N/A | 1.00x | 1.02x | 1.02x |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.10M | -13.75x | N/A | N/A | N/A |
Interest Coverage
-23924.8x
Debt/Equity
0.00
Current Ratio
40.30
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-10-31 | -23924.83x |
| 2021-07-31 | -2191.33x |
| 2021-04-30 | -995.14x |
| 2021-01-31 | -3039.55x |
| 2020-10-31 | -1402.53x |
| 2020-07-31 | -2272.36x |
| 2017-01-31 | -9786.37x |
| 2016-10-31 | -2736.50x |
| 2016-01-31 | -14223.42x |
| 2015-10-31 | -8432.05x |
| 2015-01-31 | -959.52x |
| 2014-10-31 | -3012.75x |
| 2014-07-31 | -596.97x |
| 2014-04-30 | -4933.65x |
| 2014-01-31 | -181.04x |
| 2013-10-31 | -124.40x |
| 2013-07-31 | -135.32x |
| 2013-04-30 | -12.27x |
| 2013-01-31 | -85.60x |
| 2012-10-31 | -5.19x |
| 2012-07-31 | -11.70x |
| 2012-04-30 | -3.48x |
| 2012-01-31 | -11.47x |
| 2011-10-31 | -12.08x |
| 2011-07-31 | -19.53x |
| 2011-04-30 | -6.36x |
| 2011-01-31 | -1.24x |
| 2010-10-31 | -0.72x |
| 2010-07-31 | -1.44x |
| 2010-04-30 | 4.67x |
| 2010-01-31 | -28.69x |
| 2009-10-31 | -9.99x |
| 2009-07-31 | -10.25x |
| 2009-04-30 | -160.01x |
| 2009-01-31 | -2294.98x |
| 2008-10-31 | -7353.07x |
| 2008-07-31 | -1305.19x |